Plain-English translation of NCT07114159 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Ulcerative Colitis research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing sacral nerve stimulation — a procedure where a device gently stimulates a nerve in your lower spine — to see if it can help control ulcerative colitis symptoms when standard medications haven't worked. Researchers want to learn whether this treatment is safe and effective over the long term for patients like you whose disease hasn't responded well to drugs.
Ulcerative colitis is becoming more common, especially in China and other developing countries, and many patients don't respond well enough to current medications like steroids and immunosuppressants. This trial exists to explore whether this treatment offers a new option for people whose disease has proven difficult to control with drugs alone.
You likely qualify if…
You likely don't qualify if…
You would receive sacral nerve stimulation, a procedure in which a device is placed to stimulate a nerve in your lower spine to help control your symptoms. The trial will follow you over time to carefully monitor whether this treatment is safe and how well it works for your ulcerative colitis.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
China
Sponsor
Xijing Hospital
Enrollment target
~15 participants
Started
August 2025
Primary completion
December 2032
Age range
18 Years – 65 Years
Last updated on clinicaltrials.gov in August 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Jian Wan
Xijing Hospital
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.